| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64850-893-01 | 64850-893 | HUMAN PRESCRIPTION DRUG | Loxapine | Loxapine | CAPSULE | ORAL | 20200127 | N/A | ANDA | ANDA076868 | Elite Laboratories, Inc. | LOXAPINE SUCCINATE | 50 mg/1 | 100 CAPSULE in 1 BOTTLE (64850-893-01) |
| 64850-892-01 | 64850-892 | HUMAN PRESCRIPTION DRUG | Loxapine | Loxapine | CAPSULE | ORAL | 20200127 | N/A | ANDA | ANDA076868 | Elite Laboratories, Inc. | LOXAPINE SUCCINATE | 25 mg/1 | 100 CAPSULE in 1 BOTTLE (64850-892-01) |
| 64850-891-01 | 64850-891 | HUMAN PRESCRIPTION DRUG | Loxapine | Loxapine | CAPSULE | ORAL | 20200127 | N/A | ANDA | ANDA076868 | Elite Laboratories, Inc. | LOXAPINE SUCCINATE | 10 mg/1 | 100 CAPSULE in 1 BOTTLE (64850-891-01) |
| 64850-890-01 | 64850-890 | HUMAN PRESCRIPTION DRUG | Loxapine | Loxapine | CAPSULE | ORAL | 20200127 | N/A | ANDA | ANDA076868 | Elite Laboratories, Inc. | LOXAPINE SUCCINATE | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (64850-890-01) |